NT-001

**NT-001** is an investigational class 1 biologic injection being developed by Nekon Bio for **advanced breast cancer**. Publicly available Chinese-language company and CRO materials indicate that it is an **immune cell therapy product** generated through **ex vivo induction and expansion** to enrich a high proportion of **memory immune cells**, which are intended to kill breast tumor cells. The exact cell subtype, molecular target, and detailed mechanism have not been publicly disclosed in the identified sources. Guangdong Lewwin Pharmaceutical Research Institute appears to have supported the program as a **non-clinical CRO partner**, while Nekon Bio is the developer. Available reports indicate that the product received authorization in China to begin clinical testing for advanced breast cancer.

Other names

NT-001 injectionNT001 injectionNT 001 injection